<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02431377</url>
  </required_header>
  <id_info>
    <org_study_id>14.23.INF</org_study_id>
    <nct_id>NCT02431377</nct_id>
  </id_info>
  <brief_title>Acceptability and GI Tolerance of an Alpha-lactalbumin-enriched Formula</brief_title>
  <official_title>Acceptability and GI Tolerance of an Alpha-lactalbumin-enriched Formula: An Uncontrolled, Open-label, Descriptive Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Nestlé</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Nestlé</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      A single center, non-controlled trial to document the gastrointestinal (GI) tolerability of
      the study formula (SF), containing a whey protein concentrate enriched with alpha-lactalbumin
      (WPC alpha-lac) fed for 6 weeks to healthy, term infants.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The purpose of this study is to examine the tolerable and acceptability of an infant formula
      with with a Whey protein concentrate containing alpha-lactalbumin as measure by GI tolerance,
      and eating behaviors.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>April 2015</start_date>
  <completion_date type="Actual">October 2015</completion_date>
  <primary_completion_date type="Actual">September 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Infant Gastrointestinal Symptom Questionnaire Composite Index Score</measure>
    <time_frame>6 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Formula Intake volume</measure>
    <time_frame>6 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Stool Consistency Score</measure>
    <time_frame>6 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Infant Toddler Quality of Life Profile</measure>
    <time_frame>6 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Baby Eating Behaviour Questionnaire Profile</measure>
    <time_frame>6 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Infant Characteristics Questionnaire (ICQ) Profile</measure>
    <time_frame>6 weeks</time_frame>
  </secondary_outcome>
  <other_outcome>
    <measure>Clinician-reported GI Adverse Event Profile</measure>
    <time_frame>6 weeks</time_frame>
  </other_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">40</enrollment>
  <condition>Infant Formula Intolerance</condition>
  <arm_group>
    <arm_group_label>S-26 Gold</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Standard Infant Formula containing enriched with alpha-lactalbumin</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>S-26 Gold</intervention_name>
    <description>A commercial whey protein dominant, first age formula, containing whey protein concentrate with alpha-lactalbumin</description>
    <arm_group_label>S-26 Gold</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Written informed consent

          2. Healthy, full term, singleton infant

          3. Be between 28±7 days post-natal age

          4. Infants at enrollment, weight-for-age ≥ 5th and ≤ 95th percentile according to World
             Health Organization growth tables / charts

          5. Infants must be exclusively consuming and tolerating a cow's milk infant formula for a
             minimum of 3 consecutive days and parent(s)/LAR must have previously made the decision
             to continue to exclusively formula feed

          6. Have sufficient command of Tagalog or English language to complete the informed
             consent and other study documents

          7. Are willing and able to fulfill the requirements of the study protocol

          8. Have reached the legal age of consent in the Philippines

          9. Able to be contacted by telephone throughout the study

        Exclusion Criteria:

          1. Infants who are receiving any amount of supplemental human milk

          2. Family history of siblings with documented cow's milk protein intolerance/allergy

          3. Conditions requiring infant feedings other than those specified in the protocol
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>35 Days</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Elvira M Estorninos, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Asian Hospital and Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Asian Hospital and Medical Center</name>
      <address>
        <city>Alabang</city>
        <state>Muntinlupa City</state>
        <zip>1780</zip>
        <country>Philippines</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Philippines</country>
  </location_countries>
  <verification_date>October 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 7, 2015</study_first_submitted>
  <study_first_submitted_qc>April 27, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 1, 2015</study_first_posted>
  <last_update_submitted>November 2, 2015</last_update_submitted>
  <last_update_submitted_qc>November 2, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 3, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>infant formula</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

